Allegro Diagnostics
Latest round
- Series A
Last raised
- Jun 2011
Total raised
- $9.4M
Investors
- 3
About Allegro Diagnostics
Allegro Diagnostics, founded in 2006 and headquartered in Maynard, US, focuses on developing advanced diagnostic tools. The company has undergone significant changes, including its acquisition by Veracyte Inc. in September 2014 for USD 21 mn. Allegro Diagnostics has participated in 4 deals in total, with its most recent deal occurring on September 4, 2014.AllegroDX specializes in advanced diagnostic solutions, focusing on providing innovative testing products and services for the healthcare sector. Their core offerings include a range of proprietary assays and testing platforms designed to aid in the early detection and monitoring of various medical conditions. These products aim to address critical needs in patient care, particularly in the fields of oncology, infectious diseases, and chronic conditions, facilitating timely and accurate diagnoses. AllegroDX serves a diverse client base, including hospitals, clinical laboratories, and healthcare providers primarily in North America and select markets in Europe and Asia.AllegroDX generates revenue through a subscription-based model for its diagnostic testing services, complemented by B2B sales to healthcare institutions. Their revenue structure includes direct transactions with hospitals and laboratories that utilize their testing platforms and assays in patient care settings. Typically, clients engage in partnerships that allow for bulk purchasing of their flagship diagnostic products, ensuring reliable access to essential testing resources. Pricing plans are structured around individual tests and service packages tailored to meet the specific needs of healthcare providers, facilitating streamlined operations in clinical environments.Allegro Diagnostics is focused on expanding its product offerings and geographic reach. The company is in the process of developing new diagnostic products aimed at improving detection capabilities in oncology and infectious diseases. Future plans include targeting expansion into new markets across Europe and Asia by 2025. will be utilized to support these product developments and to enhance market penetration efforts.
Who invested in Allegro Diagnostics
3 investors across 2 rounds
See all investors in Allegro Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Allegro Diagnostics
Who invested in Allegro Diagnostics?
Allegro Diagnostics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Allegro Diagnostics raised?
Allegro Diagnostics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Allegro Diagnostics last raise money?
Allegro Diagnostics's most recent round on record is a Series A, in Jun 2011.
What does Allegro Diagnostics do?
Allegro Diagnostics, founded in 2006 and headquartered in Maynard, US, focuses on developing advanced diagnostic tools.
Where is Allegro Diagnostics headquartered?
Allegro Diagnostics is headquartered in Maynard, US.
Which VCs invest in companies like Allegro Diagnostics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Allegro Diagnostics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Allegro Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.